Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak
在阿巴拉契亚艾滋病毒爆发的背景下确定减少耻辱的目标
基本信息
- 批准号:10415554
- 负责人:
- 金额:$ 20.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcute HepatitisAddressAffectAppalachian RegionCaringCenters for Disease Control and Prevention (U.S.)CommunitiesContinuity of Patient CareCountyDataDevelopmentDisease OutbreaksDropsDrug usageEarly DiagnosisEnsureEquipmentFamilyFoundationsGeneral PopulationGoalsHIVHIV diagnosisHealth PersonnelHepatitis BHepatitis CHuman immunodeficiency virus testIncidenceIndianaIndividualInfectionInjecting drug userInjectionsInterventionInterviewInvestigationKnowledgeLocationMeasuresMethodsModelingNeedle SharingNeedle-Exchange ProgramsOverdoseOxymorphonePharmaceutical PreparationsPhasePopulationPopulations at RiskPreventionPrevention programProviderResearchRuralRural AppalachiaRural CommunitySamplingServicesSiteSourceSurveysTestingViralWest Virginiabasedisease transmissiondrug testingevidence baseexperiencehealth care service utilizationhealth service usehigh riskimprovedinjection drug useinnovationinsightinterestinternalized stigmanovelopioid epidemicphase 1 studypre-exposure prophylaxisprevention serviceprogramsresponserural Americarural areascale upservice utilizationsocial stigmasubstance usetesting servicestesting uptaketherapy designtooltransmission processuptakeurban areavulnerable community
项目摘要
PROJECT SUMMARY/ABSTRACT
This study will examine how drug-related stigma influences the utilization of HIV prevention and testing
programs among people who inject drugs (PWID) in the context of ongoing HIV outbreaks in Appalachia. The
opioid crisis has contributed to high levels of injection drug use in rural communities, leaving them highly
vulnerable to HIV outbreaks. Scaling up evidence-based HIV prevention and testing programs is critical for
averting these outbreaks but even where these programs exist, often they are not used by PWID. Drug-related
stigma may pose a substantial barrier to engaging in these services, especially in rural communities where
anonymity and confidentiality are difficult to maintain. However, there is limited research on how drug-related
stigma and its individual constructs (e.g., enactedstigma, anticipated stigma, internalized stigma) affect
program uptake among PWID. Our study will used a sequential mixed methods approach to fill these
knowledge gaps by (1) exploring the ways in which stigma influences the utilization of HIV prevention and
testing programs among rural PWID, (2) adapting and validating an existing stigma scale, the Substance Use
Stigma Mechanisms Scale (SU-SMS), for rural PWID, and (3) characterizing the types and sources of stigma
that serve as barriers to HIV prevention and testing program participation in this population. The study will be
conducted at two sites in West Virginia, which is the location of ongoing HIV outbreaks fueled by injection drug
use. In Phase I of the study, we will conduct qualitative interviews with PWID (N=40) and healthcare providers
(N=24) to provide insight into how stigma is operationalized in the context of HIV services utilization. In Phase
II, we will conduct a survey of PWID (N=300) to adapt and validate the SU-SMS. Then, we will model the
association between individual stigma constructs and HIV prevention and testing program use while also
considering other structural- and individual-level factors that influence healthcare utilization. The resulting
information will assist us in targeting, developing, and testing novel stigma-reduction interventions designed to
improve rural PWID engagement in HIV prevention and testing services, with the ultimate goal of reducing HIV
transmission among PWID in rural communities.
项目总结/摘要
这项研究将探讨与毒品有关的耻辱感如何影响艾滋病毒预防和检测的利用
在阿巴拉契亚地区艾滋病毒持续爆发的背景下,在注射毒品者(PWID)中开展的项目。的
阿片类药物危机导致农村社区注射毒品的使用率很高,
容易受到艾滋病毒爆发的影响。扩大以证据为基础的艾滋病毒预防和检测方案对于
但即使存在这些程序,PWID通常也不会使用它们。药物相关
污名化可能对参与这些服务构成重大障碍,特别是在农村社区,
匿名性和保密性难以维持。然而,关于如何与毒品有关的研究有限。
污名及其个体结构(例如,预期污名,内化污名)情感
项目在PWID中的应用。我们的研究将采用序贯混合方法的方法来填补这些
(1)探讨污名化如何影响艾滋病毒预防的利用,
在农村PWID中测试项目,(2)调整和验证现有的耻辱量表,物质使用
污名机制量表(SU-SMS),用于农村PWID;(3)表征污名的类型和来源
这是该人群参与艾滋病预防和检测项目的障碍。本研究将
在西弗吉尼亚州的两个地点进行,这是正在进行的艾滋病毒爆发的地方,由注射毒品推动
使用.在研究的第一阶段,我们将对PWID(N=40)和医疗保健提供者进行定性访谈
(N=24),以了解如何在艾滋病毒服务利用的背景下运作的耻辱。同相
第二,我们将进行PWID调查(N=300),以适应和验证SU-SMS。然后,我们将对
个人污名结构与艾滋病毒预防和检测项目使用之间的关联,
考虑到影响医疗保健利用的其他结构和个人因素。所得
信息将帮助我们瞄准,开发和测试新的减少耻辱的干预措施,
改善农村艾滋病感染者参与艾滋病毒预防和检测服务,最终目标是减少艾滋病毒感染
在农村社区的PWID中传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robin A Pollini其他文献
Robin A Pollini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robin A Pollini', 18)}}的其他基金
Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak
在阿巴拉契亚艾滋病毒爆发的背景下确定减少耻辱的目标
- 批准号:
10670313 - 财政年份:2022
- 资助金额:
$ 20.31万 - 项目类别:
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
药房纳洛酮分布:评估降低用药过量死亡率的新工具
- 批准号:
9629678 - 财政年份:2017
- 资助金额:
$ 20.31万 - 项目类别:
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
药房纳洛酮分布:评估降低用药过量死亡率的新工具
- 批准号:
10092988 - 财政年份:2017
- 资助金额:
$ 20.31万 - 项目类别:
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
药房纳洛酮分布:评估降低用药过量死亡率的新工具
- 批准号:
9113804 - 财政年份:2016
- 资助金额:
$ 20.31万 - 项目类别:
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California
销售非处方药注射器以预防加利福尼亚州内陆服务欠缺地区的艾滋病毒
- 批准号:
8780622 - 财政年份:2013
- 资助金额:
$ 20.31万 - 项目类别:
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California
销售非处方药注射器以预防加利福尼亚州内陆服务欠缺地区的艾滋病毒
- 批准号:
8466903 - 财政年份:2013
- 资助金额:
$ 20.31万 - 项目类别:
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California
销售非处方药注射器以预防加利福尼亚州内陆服务欠缺地区的艾滋病毒
- 批准号:
8601068 - 财政年份:2013
- 资助金额:
$ 20.31万 - 项目类别:
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach
定义墨西哥药房在艾滋病毒预防中的作用——混合方法
- 批准号:
8283008 - 财政年份:2007
- 资助金额:
$ 20.31万 - 项目类别:
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach
定义墨西哥药房在艾滋病毒预防中的作用——混合方法
- 批准号:
7497029 - 财政年份:2007
- 资助金额:
$ 20.31万 - 项目类别:
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach
定义墨西哥药房在艾滋病毒预防中的作用——混合方法
- 批准号:
7908794 - 财政年份:2007
- 资助金额:
$ 20.31万 - 项目类别:
相似海外基金
ISARIC CCP activation for acute hepatitis of unknown cause
ISARIC CCP 激活治疗不明原因急性肝炎
- 批准号:
MR/X010252/1 - 财政年份:2022
- 资助金额:
$ 20.31万 - 项目类别:
Research Grant
Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfection
在有或没有 HIV-1 合并感染的急性乙型肝炎自然控制过程中中和抗体反应
- 批准号:
10402216 - 财政年份:2022
- 资助金额:
$ 20.31万 - 项目类别:
Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfection
在有或没有 HIV-1 合并感染的急性乙型肝炎自然控制过程中中和抗体反应
- 批准号:
10674691 - 财政年份:2022
- 资助金额:
$ 20.31万 - 项目类别:
Biomarkers of spontaneous acute hepatitis C virus resolution
自发性急性丙型肝炎病毒消退的生物标志物
- 批准号:
8262303 - 财政年份:2012
- 资助金额:
$ 20.31万 - 项目类别:
Biomarkers of spontaneous acute hepatitis C virus resolution
自发性急性丙型肝炎病毒消退的生物标志物
- 批准号:
8458955 - 财政年份:2012
- 资助金额:
$ 20.31万 - 项目类别:
Effects of Vitamin E Derevative , ETS-GS for the treatment of acute hepatitis
维生素E衍生物ETS-GS治疗急性肝炎的疗效
- 批准号:
23592260 - 财政年份:2011
- 资助金额:
$ 20.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation the mechanisms of chronicity from acute hepatitis B using a next generation sequencer
使用下一代测序仪研究急性乙型肝炎的慢性机制
- 批准号:
22790679 - 财政年份:2010
- 资助金额:
$ 20.31万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
8625266 - 财政年份:2010
- 资助金额:
$ 20.31万 - 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
- 批准号:
9900734 - 财政年份:2010
- 资助金额:
$ 20.31万 - 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
8445240 - 财政年份:2010
- 资助金额:
$ 20.31万 - 项目类别: